| Code ID
|
52307 |
| Result (%)
|
93,33 |
|
Evaluation through structured dialogue
|
Although the result is not in the target area, the quality target is still considered to have been achieved. For more information, see All information (click here) at the bottom under Comment or Technical note. (H99)
|
| Population
|
30 |
| Events observed
|
28 |
| Anticipated events
|
0,00 |
| Result trend compared with the previous reporting year
|
eingeschränkt/nicht vergleichbar |
| Comparison with the previous reporting year
|
eingeschränkt/nicht vergleichbar |
| National result (%)
|
98,43 |
| Target range (reference range)
|
>= 95,00 % |
| Confidence interval nationwide (%)
|
98,34 - 98,53 |
| Hospital confidence interval (%)
|
78,68 - 98,15 |
| Reference infection
|
No |
| Type of value
|
QI |
| Relation to the procedure
|
DeQS |
| Reference to other QA results |
|
| Sorting |
|
| Risk-adjusted rate |
|
| Comments/explanations by the competent authority at national or state level
|
Der Leistungserbringer wurde auf das rechnerisch auffällige Ergebnis hingewiesen und zur internen Analyse der rechnerischen Auffälligkeit aufgefordert. |
| Comments/explanations by the hospital
|
Die im Rahmen des Stellungnahmeverfahrens analysierten Probleme wurden besprochen und entsprechende Maßnahmen zur Verbesserung der Ergebnisse umgesetzt. |
Specialist note IQTIG
The reference range indicates the results at which a facility can be assumed to provide good quality of care, although deviations are possible. The reference range thus sets a benchmark for the assessment of facilities. A result outside the reference range is initially considered conspicuous. This usually entails an analysis by means of a statement procedure. It should be noted that a quality result outside the reference range is not synonymous with a lack of quality of the facility in the quality aspect considered here. The deviation can also be due, for example, to faulty documentation, medical specificity of the patient collective or individual cases. The assessment of quality is carried out within the framework of the defined procedure in the comments procedure. Further information on reference ranges can be found under the following link: https://iqtig.org/das-iqtig/grundlagen/methodische-grundlagen. The choice of system for defibrillator implantation is assessed according to the current guidelines on pacemaker and cardiac resynchronisation therapy, on the diagnosis and treatment of heart failure, and on the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (Brignole et al. 2013, Glikson et al. 2021, McDonagh 2021, Priori et al. 2015). In individual cases, there may be justified deviations from the guidelines if defibrillators are implanted, e.g. as part of studies or when testing new procedures. - Brignole, M: Auricchio, A: Baron-Esquivias, G: Bordachar, P: Boriani, G: Breithardt, O-A: et al. (2013): 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eu ropean Heart Journal 34(29): 2281-2329. DOI: 10.1093/eu rheartj/eht150. - Glikson, M: Nielsen, JC: Kronborg, MB: Michowitz, Y: Auric chio, A: Barbash, IM: et al. (2021): 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Euro pean Heart Journal 42(35): 3427-3520. DOI: 10.1093/eurhe artj/ehab364. - McDonagh, TA: Metra, M: Adamo, M: Gardner, RS: Baum bach, A: Böhm, M: et al. (2021): 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal 42(36): 3599-3726. DOI: 10.1093/eu rheartj/ehab368. - Priori, SG: Blomström-Lundqvist, C: Mazzanti, A: Blom, N: Borggrefe, M: Camm, J: et al. (2015): 2015 ESC Guidelines for the management of patients with ventricular arrhythmias. |
